Abstract
Lack of matrix deposition is one of the main factors that complicates the healing process of wounds. The aim of this study was to test the efficacy and safety of a liquid dermal scaffold, referred to as MeshFill (MF), that can fill the complex network of tunnels and cavities which are usually found in chronic wounds and hence improve the healing process.
We evaluated the in vitro and in vivo properties of a novel liquid dermal scaffold in a delayed murine full thickness wound model. We also compared this scaffold with two commercially- available granular collagen-based products (GCBP).
Liquid dermal scaffold accelerated wound closure significantly compared to no-treated control and collagen-based injectable composites in a delayed splinted wound model. When we compared cellular composition and count between the MF, no treatment, and GCBP at the histology level, it was found that MF was the most analogous and consistent to the normal anatomy of the skin. These findings were matched with the clinical outcome observation.
The flowable in situ-forming scaffold is liquid at cold temperature and gels after application to the wound site. Therefore, it would conform to the topography of the wound when liquid and provides adequate tensile strength when solidified. This patient-ready gelling dermal scaffold also contains the nutritional ingredients and therefore supports cell growth.
Applying an injectable liquid scaffold that can fill wound gaps and generate a matrix to promote keratinocytes and fibroblasts migration, can result in improvement of the healing process of complex wounds.
No comments:
Post a Comment